Table 2 Associations with NSC status
OR | 95% CI | p | |
|---|---|---|---|
Sociodemographic characteristics | |||
Age, per year | 1.01 | (1.00–1.02) | 0.040 |
Sex | |||
Female | 1.00 | (base) | |
Male | 1.53 | (1.12–2.09) | 0.007 |
Swiss nationality | 1.22 | (0.86–1.73) | 0.259 |
Private insurance | 1.78 | (1.21–2.61) | 0.003 |
Transport by EMS | 0.80 | (0.56–1.14) | 0.221 |
Time and day of admission to ED | |||
Saturday or Sunday | 0.75 | (0.53–1.05) | 0.096 |
Night-time admission | 0.77 | (0.57–1.05) | 0.102 |
Effective weekendsa | 0.65 | (0.47–0.91) | 0.011 |
Effective days offb | 0.76 | (0.54–1.06) | 0.106 |
Comorbidity | |||
COPD | 0.69 | (0.33–1.44) | 0.326 |
Diabetes | 2.07 | (1.36–3.15) | 0.001 |
Dementia | 1.56 | (0.61–3.95) | 0.352 |
Past myocardial infarction | 0.67 | (0.40–1.11) | 0.121 |
Malignancy | 1.14 | (0.76–1.72) | 0.521 |
Peripheral artery disease | 0.55 | (0.19–1.62) | 0.279 |
Chronic kidney disease | 1.16 | (0.54–2.46) | 0.708 |
Cerebrovascular disease | 1.14 | (0.64–2.02) | 0.655 |
Drug intake | |||
On any antidiabetic | 1.94 | (1.20–3.13) | 0.007 |
On any antithrombotic | 1.02 | (0.69–1.53) | 0.905 |
On any antihypertensive | 1.19 | (0.80–1.78) | 0.397 |
On any diuretic | 0.81 | (0.49–1.33) | 0.400 |
On any opioids | 0.84 | (0.46–1.53) | 0.561 |
On any antiepileptic | 1.04 | (0.58–1.88) | 0.893 |
On any psycholeptic | 1.01 | (0.64–1.59) | 0.981 |
Consultation characteristic | |||
Triage category | |||
Urgent | 1.00 | (base) | |
Highly-urgent | 0.50 | (0.36–0.70) | < 0.001 |
Outcomes | |||
Hospitalisation | 0.94 | (0.69–1.28) | 0.693 |
30 days revisits | 0.85 | (0.53–1.36) | 0.498 |
365 days revisits | 1.09 | (0.80–1.50) | 0.577 |
LOS hospital days | 1.01 | (0.99–1.03) | 0.564 |
LOS ED hours | 0.99 | (0.95–1.04) | 0.777 |
ICU admission | 0.82 | (0.45–1.48) | 0.508 |
In-hospital death | 1.66 | (0.62–4.45) | 0.315 |